{"id":49047,"date":"2022-09-30T19:02:26","date_gmt":"2022-09-30T17:02:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/"},"modified":"2022-09-30T19:02:26","modified_gmt":"2022-09-30T17:02:26","slug":"verismas-leadership-team-expands","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/","title":{"rendered":"Verisma\u2019s Leadership Team Expands"},"content":{"rendered":"
\n

\nRecapitalization and growth projections spur new hires and promotions<\/i>\n<\/p>\n

WASHINGTON–(BUSINESS WIRE)–Verisma\u2019s leadership team is expanding to prepare for further growth less than a year after NewSpring announced a recapitalization<\/a> and continued investment in the company.\n<\/p>\n

<\/a><\/p>\n

\nVerisma\u2019s CEO, Marty McKenna, shared his thoughts on these leadership changes:
\n
\u201cWith increasing compliance regulations, staff shortages, and other shifts in health information management, a trusted partner in the complete disclosure management process from release of information (ROI) and beyond is more important now than ever. Verisma\u2019s move toward scale and growth means healthcare providers can worry less about human errors, penalties, and turnaround time and focus more on life-saving care.\u201d\n<\/p>\n

\nMichael Fritts was named Chief Operations Officer, bringing leadership experience from GE Healthcare and multiple successful start-ups. He earned his Bachelor of Science in Electrical Engineering at South Dakota School of Mines and Technology and his MBA from Northwestern University\u2019s Kellogg School of Management. He also holds a certification in Six Sigma.\n<\/p>\n

\nSteve Aylward was named Chief Revenue Officer. He has excelled in a variety of leadership roles across the healthcare industry. These include his tenure as Senior Vice President at AmWell, Change Healthcare, and Agfa, as well as General Manager for US Health & Life Sciences at Microsoft. Steve will drive client acquisition and revenue growth in his new position. A graduate of UCLA, he is serving in his tenth year on the Board of Trustees for Paoli Hospital, part of Main Line Health.\n<\/p>\n

\nJulia Applegate was promoted to Chief Client Officer. More than 20 years of management experience in ROI has prepared Julia for this role. She will focus on expanding Verisma\u2019s offerings beyond health information management (HIM) services and into departments like compliance, revenue cycle, managed care, and radiology.\n<\/p>\n

\nDelinda Tinkey was hired as Director of Marketing, solidifying our strategic focus on brand growth. She brings a blend of healthcare and technology experience at electronic health record (EHR) and SaaS organizations. Most recently, she was Director of Marketing Operations for one of the country\u2019s largest addiction treatment providers.\n<\/p>\n

\nAbout Verisma
\n
<\/b>With Verisma\u00ae services and technology, health information managers elevate their organization\u2019s method of securely disclosing confidential information to patients, attorneys, and other third parties. Built on the principles of truth and accuracy, Verisma is a trusted partner in complying with changing regulations while reducing errors, turnaround time, and cost.\n<\/p>\n

\nVerisma HITRUST\u00ae certified technology integrates with existing EHRs and portals for advanced automation and transparency uniquely designed for release of information (ROI), self-serve request tracking, and audits.\n<\/p>\n

\nFlexible service models including full-service, technology-only, or a hybrid seamlessly blend Verisma\u2019s end-to-end solution with the needs of existing staff. Our partnership is truly a promise to put patient protection first.\n<\/p>\n

\nLearn more about our disclosure management system at verisma.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDelinda Tinkey
\n
Verisma
\n
866.390.7404
\n
dtinkey@verisma.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Recapitalization and growth projections spur new hires and promotions WASHINGTON–(BUSINESS WIRE)–Verisma\u2019s leadership team is expanding to prepare for further growth less than a year after NewSpring announced a recapitalization and continued investment in the company. Verisma\u2019s CEO, Marty McKenna, shared his thoughts on these leadership changes: \u201cWith increasing compliance regulations, staff shortages, and other shifts … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49047","6":"format-standard","7":"category-industry"},"yoast_head":"\nVerisma\u2019s Leadership Team Expands - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verisma\u2019s Leadership Team Expands - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Recapitalization and growth projections spur new hires and promotions WASHINGTON–(BUSINESS WIRE)–Verisma\u2019s leadership team is expanding to prepare for further growth less than a year after NewSpring announced a recapitalization and continued investment in the company. Verisma\u2019s CEO, Marty McKenna, shared his thoughts on these leadership changes: \u201cWith increasing compliance regulations, staff shortages, and other shifts ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-30T17:02:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220930005413\/en\/1588369\/21\/Verisma_Logo_Horz_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Verisma\u2019s Leadership Team Expands\",\"datePublished\":\"2022-09-30T17:02:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/\"},\"wordCount\":477,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220930005413\\\/en\\\/1588369\\\/21\\\/Verisma_Logo_Horz_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/\",\"name\":\"Verisma\u2019s Leadership Team Expands - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220930005413\\\/en\\\/1588369\\\/21\\\/Verisma_Logo_Horz_RGB.jpg\",\"datePublished\":\"2022-09-30T17:02:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220930005413\\\/en\\\/1588369\\\/21\\\/Verisma_Logo_Horz_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220930005413\\\/en\\\/1588369\\\/21\\\/Verisma_Logo_Horz_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verismas-leadership-team-expands\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Verisma\u2019s Leadership Team Expands\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Verisma\u2019s Leadership Team Expands - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/","og_locale":"en_US","og_type":"article","og_title":"Verisma\u2019s Leadership Team Expands - Pharma Trend","og_description":"Recapitalization and growth projections spur new hires and promotions WASHINGTON–(BUSINESS WIRE)–Verisma\u2019s leadership team is expanding to prepare for further growth less than a year after NewSpring announced a recapitalization and continued investment in the company. Verisma\u2019s CEO, Marty McKenna, shared his thoughts on these leadership changes: \u201cWith increasing compliance regulations, staff shortages, and other shifts ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-30T17:02:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220930005413\/en\/1588369\/21\/Verisma_Logo_Horz_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Verisma\u2019s Leadership Team Expands","datePublished":"2022-09-30T17:02:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/"},"wordCount":477,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220930005413\/en\/1588369\/21\/Verisma_Logo_Horz_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/","url":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/","name":"Verisma\u2019s Leadership Team Expands - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220930005413\/en\/1588369\/21\/Verisma_Logo_Horz_RGB.jpg","datePublished":"2022-09-30T17:02:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220930005413\/en\/1588369\/21\/Verisma_Logo_Horz_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220930005413\/en\/1588369\/21\/Verisma_Logo_Horz_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/verismas-leadership-team-expands\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Verisma\u2019s Leadership Team Expands"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49047","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49047"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49047\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}